Aquablation, Prostatic Urethral Lift, and Transurethral Water Vapor Therapy: A Comparison of Device Related Adverse Events in a National Registry.

Aquablation, prostatic urethral lift (PUL), and transurethral water vapor therapy (TWVT) have demonstrated efficacy for the treatment of benign prostatic hyperplasia (BPH). Our objective was to describe device malfunctions and complications to help guide procedural selection and performance.

The Manufacturer and User Facility Device Experience (MAUDE) database was examined for reports related to the use of these three procedures for the treatment of BPH between January 1, 2015 and July 1, 2020. Reports were evaluated for device malfunctions and surgical complications using a previously described externally validated classification system developed for the MAUDE database. Chi square analysis was used for statistical comparison between groups.

A total of 391 adverse events were reported: Aquablation (n=102), PUL (n=132), and TWVT (n=157). There were 79 (78%) severe or life threatening adverse events for Aquablation vs. 69 (52%) for PUL vs. 24 (15%) for TWVT (p < 0.001). There were 4 cases of rectal perforation with Aquablation and 25 cases of the PUL implants needing to be removed or causing a problem with a later procedure. Blood transfusion frequencies were: Aquablation - 32 (31%), PUL - 21 (16%), TWVT - 1 (1%). The most common device malfunctions were: Aquablation - motion error (n=8), handpiece fracture/attachment malfunction (n=8); PUL - device misfire (n=27), needle fragmentation (n=21); TWVT - unresolvable error message (n=19).

In a national database, Aquablation and PUL had noteworthy complications or device related malfunctions such as rectal perforation and the improper placement or failed deployment of the PUL implants. Both patients and providers should be aware of potential risks when selecting these novel BPH treatments.

Journal of endourology. 2021 Jul 27 [Epub ahead of print]

Elie Kaplan-Marans, Mariela Martinez, Andrew Wood, James Cochran, Elliot Dubowitch, Ariel Schulman

Maimonides Medical Center, 2042, 4802 10th Ave, New York, New York, United States, 11219; ., Maimonides Medical Center, 2042, Urology , 4802 10th Ave, Brooklyn, New York, United States, 11219-2916; ., New York, United States; ., New York, New York, United States; ., New York, United States; ., Maimonides Medical Center, 2042, Brooklyn, New York, United States; .

Go Beyond the Abstract and Read a Commentary by the Authors